Targeting MTHFR for the treatment of migraines
- 28 November 2018
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Targets
- Vol. 23 (1) , 29-37
Abstract
Introduction: Migraine is a common neurovascular disorder classified by the World Health Organization as one of the most debilitating diseases. Migraine is a complex disease and is a consequence of an interaction between genetic, epigenetic and environmental factors. The MTHFR gene is one of the few replicated genetic risk factors for migraine and encodes an enzyme that is crucial for the folate and the methionine cycles. Individuals carrying the T allele of the MTHFR C677T polymorphism have increased plasma concentrations of homocysteine which leads to endothelial cell injury and alterations in coagulant properties of blood. Areas covered: This review focuses on the recent advances in genetics and the role of the MTHFR gene and homocysteine metabolism in migraine etiopathogenesis. The article summarizes the potential of targeting MTHFR and homocysteine for disease prevention. Expert opinion: Determination of MTHFR C677T polymorphisms as well as measurement of homocysteine concentrations may be useful to migraine patients, particularly those suffering from migraine with aura. Preliminary studies support the use of folate, vitamin B6 and vitamin B12 for the prevention of migraine. However, the results of these studies await replication in larger randomized controlled clinical trials.Keywords
Funding Information
- Ministero dell’Università e della Ricerca Scientifica (MIUR) of Italy
This publication has 95 references indexed in Scilit:
- Epigenetic mechanisms in migraine: a promising avenue?BMC Medicine, 2013
- Homocysteine plasma levels in patients treated with antiepileptic drugs depend on folate and vitamin B12 serum levels, but not on genetic variants of homocysteine metabolismClinical Chemistry and Laboratory Medicine (CCLM), 2013
- The Role of the MTHFR Gene in MigraineHeadache: The Journal of Head and Face Pain, 2012
- Homocysteine and Coronary Heart Disease: Meta-analysis of MTHFR Case-Control Studies, Avoiding Publication BiasPLOS Medicine, 2012
- Properties and Crystal Structure of Methylenetetrahydrofolate Reductase from Thermus thermophilus HB8PLOS ONE, 2011
- Methylenetetrahydrofolate Reductase Gene Variant (MTHFR C677T) and Migraine: A Case Control Study and Meta-analysisBMC Neurology, 2011
- Analysis of the MTHFR C677T variant with migraine phenotypesBMC Research Notes, 2010
- MTHFR 677C>T and ACE D/I Polymorphisms in Migraine: A Systematic Review and Meta‐AnalysisHeadache: The Journal of Head and Face Pain, 2010
- The Migraine Association with Cardiac Anomalies, Cardiovascular Disease, and StrokeNeurologic Clinics, 2009
- Drugs Affecting Homocysteine MetabolismDrugs, 2002